Skin cancer in organ transplant recipients: Effects of immunosuppressive medications on DNA repair

Experimental Dermatology

Volumn 21, Issue 1, 2012, Pages 2-6

  Kuschal, Christiane ^a   Thoms, Kai Martin ^a   Schubert, Steffen ^a   Schäfer, Annika ^a   Boeckmann, Lars ^a   Schön, Michael P ^a   Emmert, Steffen ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Azathioprine; Calcineurin inhibitors; DNA repair; MTOR inhibitors; Nucleotide excision repair; UV induced skin cancer

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; EVEROLIMUS; PREDNISOLONE; RAPAMYCIN; TACROLIMUS; XERODERMA PIGMENTOSUM GROUP A PROTEIN;

ARTICLE; BASAL CELL CARCINOMA; CANCER RISK; COCKAYNE SYNDROME; DIABETES MELLITUS; DNA REPAIR; DYSLIPIDEMIA; EXCISION REPAIR; GASTROINTESTINAL SYMPTOM; GENE CONTROL; GRAFT RECIPIENT; HUMAN; HYPERTENSION; MISMATCH REPAIR; NEUROLOGIC DISEASE; ORGAN TRANSPLANTATION; PROTEIN EXPRESSION; PROTEIN PROCESSING; SKIN CANCER; SQUAMOUS CELL CARCINOMA; XERODERMA PIGMENTOSUM;

CALCINEURIN; DNA REPAIR; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; ORGAN TRANSPLANTATION; SKIN NEOPLASMS; XERODERMA PIGMENTOSUM;

EID: 83455176431     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2011.01413.x     Document Type: Article

References (80)

1. Hoeijmakers J H. Nature 2001: 411: 366-374.
2. Bootsma D, Kraemer K H, Cleaver J E et al. In: Vogelstein B, Kinzler K W, eds. The Genetic Basis of Human Cancer. New York, NY: McGraw-Hill, 2002: 211-237.
3. Runger T M, Kappes U P. Photodermatol Photoimmunol Photomed 2008: 24: 2-10.
4. Lindahl T, Wood R D. Science 1999: 286: 1897-1905.
5. Emmert S, Leibeling D, Runger T M. J Dtsch Dermatol Ges 2006: 4: 721-731.
6. Shaikh R, Sachs D, Fishman J et al. Ann N Y Acad Sci 1998: 862: 237-250.
7. Marcen R. Drugs 2009: 69: 2227-2243.
8. Hofbauer G F, Bouwes Bavinck J N, Euvrard S. Exp Dermatol 2010: 19: 473-482.
9. Euvrard S, Kanitakis J, Claudy A. N Engl J Med 2003: 348: 1681-1691.
10. de Fijter J W. Nephrol Dial Transplant 2007: 22 (Suppl 1): i23-i26.
11. Ulrich C, Kanitakis J, Stockfleth E et al. Am J Transplant 2008: 8: 2192-2198.
12. Nindl I, Rosl F. Am J Transplant 2008: 8: 2199-2204.
13. Kraemer K H, Lee M M, Scotto J. Arch Dermatol 1987: 123: 241-250.
14. Emmert S. In: Allgayer H, Rehder H, Fulda S, eds. Hereditary Tumors. From Genes to Clinical Consequences. Weinheim: Wiley-VCH, 2009: 421-439.
15. Leibeling D, Laspe P, Emmert S. J Mol Histol 2006: 37: 225-238.
16. Swift M, Chase C. J Natl Cancer Inst 1979: 62: 1415-1421.
17. Qiao Y, Spitz M R, Shen H et al. Carcinogenesis 2002: 23: 295-299.
18. Blankenburg S, Konig I R, Moessner R et al. Carcinogenesis 2005: 26: 1085-1090.
19. Wei Q, Lee J E, Gershenwald J E et al. J Natl Cancer Inst 2003: 95: 308-315.
20. Wei Q, Matanoski G M, Farmer E R et al. Proc Natl Acad Sci USA 1993: 90: 1614-1618.
21. Wu X, Zhao H, Wei Q et al. Carcinogenesis 2003: 24: 505-509.
22. Cheng L, Eicher S A, Guo Z et al. Cancer Epidemiol Biomarkers Prev 1998: 7: 465-468.
23. Thoms K M, Kuschal C, Emmert S. Exp Dermatol 2007: 16: 532-544.
24. Guba M, Graeb C, Jauch K W et al. Transplantation 2004: 77: 1777-1782.
25. Moloney F J, Comber H, O'Lorcain P et al. Br J Dermatol 2006: 154: 498-504.
26. Jensen P, Hansen S, Moller B et al. J Am Acad Dermatol 1999: 40: 177-186.
27. Marcen R, Pascual J, Tato A M et al. Transplant Proc 2003: 35: 1714-1716.
28. Dantal J, Hourmant M, Cantarovich D et al. Lancet 1998: 351: 623-628.
29. Euvrard S, Ulrich C, Lefrancois N. Dermatol Surg 2004: 30: 628-633.
30. Otley C C, Maragh S L. Dermatol Surg 2005: 31: 163-168.
31. Moriwaki S, Ray S, Tarone R E et al. Mutat Res 1996: 364: 117-123.
32. Liu J, Farmer J D Jr, Lane W S et al. Cell 1991: 66: 807-815.
33. Zhang Y, Baumgrass R, Schutkowski M et al. Chembiochem 2004: 5: 1006-1009.
34. Flanagan W M, Corthesy B, Bram R J et al. Nature 1991: 352: 803-807.
35. Oetjen E, Thoms K M, Laufer Y et al. Br J Pharmacol 2005: 144: 982-993.
36. Fukudo M, Yano I, Masuda S et al. J Pharmacol Exp Ther 2005: 312: 816-825.
37. Norman K G, Canter J A, Shi M et al. Mitochondrion 2010: 10: 94-101.
38. Kasiske B L. Semin Nephrol 2000: 20: 176-187.
39. Webster A C, Woodroffe R C, Taylor R S et al. BMJ 2005: 331: 810.
40. Ahlers C, Kreideweiss S, Nordheim A et al. Eur J Biochem 1999: 264: 952-959.
41. Sugie N, Fujii N, Danno K. Photodermatol Photoimmunol Photomed 2002: 18: 163-168.
42. Yarosh D B, Pena A V, Nay S L et al. J Invest Dermatol 2005: 125: 1020-1025.
43. Herman M, Weinstein T, Korzets A et al. J Lab Clin Med 2001: 137: 14-20.
44. Thoms K M, Kuschal C, Oetjen E et al. Exp Dermatol 2011: 20: 232-236.
45. Herman M, Ori Y, Chagnac A et al. J Lab Clin Med 2002: 140: 255-262.
46. Kuschal C, Thoms K M, Boeckmann L et al. Exp Dermatol 2011: 20: 795-799.
47. Li G, Bush J A, Ho V C. J Invest Dermatol 2000: 114: 514-519.
48. Cheng L, Spitz M R, Hong W K et al. Carcinogenesis 2000: 21: 1527-1530.
49. Wang X W, Yeh H, Schaeffer L et al. Nat Genet 1995: 10: 188-195.
50. Tan T, Chu G. Mol Cell Biol 2002: 22: 3247-3254.
51. Glover M T, Deeks J J, Raftery M J et al. Lancet 1997: 349: 398.
52. O'Donovan P, Perrett C M, Zhang X et al. Science 2005: 309: 1871-1874.
53. Zhang X, Jeffs G, Ren X et al. DNA Repair (Amst) 2007: 6: 344-354.
54. Harwood C A, Attard N R, O'Donovan P et al. Br J Cancer 2008: 99: 1276-1284.
55. Brem R, Li F, Karran P. Nucleic Acids Res 2009: 37: 1951-1961.
56. Daehn I, Karran P. Cancer Res 2009: 69: 2393-2399.
57. Perrett C M, Harwood C A, McGregor J M et al. Br J Dermatol 2010: 162: 732-742.
58. de Graaf Y G, Rebel H, Elghalbzouri A et al. Exp Dermatol 2008: 17: 349-355.
59. Kauffman H M, Cherikh W S, Cheng Y et al. Transplantation 2005: 80: 883-889.
60. Mathew T, Kreis H, Friend P. Clin Transplant 2004: 18: 446-449.
61. Neuhaus P, Klupp J, Langrehr J M. Liver Transpl 2001: 7: 473-484.
62. Nojima H, Tokunaga C, Eguchi S et al. J Biol Chem 2003: 278: 15461-15464.
63. Bjornsti M A, Houghton P J. Nat Rev Cancer 2004: 4: 335-348.
64. Khariwala S S, Kjaergaard J, Lorenz R et al. Laryngoscope 2006: 116: 814-820.
65. Meier F, Guenova E, Clasen S et al. J Am Acad Dermatol 2009: 60: 863-868.
66. Checkley L A, Rho O, Moore T et al. Cancer Prev Res (Phila) 2011: 4: 1011-1020.
67. Brenneisen P, Wenk J, Wlaschek M et al. J Biol Chem 2000: 275: 4336-4344.
68. Limson M V, Sweder K S. Toxicol Sci 2010: 113: 77-84.
69. Chen H, Ma Z, Vanderwaal R P et al. Radiat Res 2011: 175: 214-224.
70. Wu X, Shell S M, Yang Z et al. Cancer Res 2006: 66: 2997-3005.
71. Shell S M, Li Z, Shkriabai N et al. J Biol Chem 2009: 284: 24213-24222.
72. Coin F, Auriol J, Tapias A et al. EMBO J 2004: 23: 4835-4846.
73. Mi J, Bolesta E, Brautigan D L et al. Mol Cancer Ther 2009: 8: 135-140.
74. Screaton R A, Conkright M D, Katoh Y et al. Cell 2004: 119: 61-74.
75. Rao A, Luo C, Hogan P G. Annu Rev Immunol 1997: 15: 707-747.
76. Santini M P, Talora C, Seki T et al. Proc Natl Acad Sci USA 2001: 98: 9575-9580.
77. Trouche D, Cook A, Kouzarides T. Nucleic Acids Res 1996: 24: 4139-4145.
78. Wu Y H, Tsai Chang J H, Cheng Y W et al. Oncogene 2007: 26: 4761-4773.
79. Adimoolam S, Ford J M. Proc Natl Acad Sci USA 2002: 99: 12985-12990.
80. Lin P S, McPherson L A, Chen A Y et al. DNA Repair (Amst) 2009: 8: 795-802.